11/19
01:20 am
csbtf
Kuros Biosciences Expands into Extremities Markets
Low
Report
Kuros Biosciences Expands into Extremities Markets
10/10
01:20 am
csbtf
Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024
Neutral
Report
Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024